Patents by Inventor Patricia Eileen Saxton
Patricia Eileen Saxton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10392561Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: GrantFiled: December 8, 2015Date of Patent: August 27, 2019Assignee: Merck Patent GmbHInventors: Detlef Pauluth, Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Hassan Arasi, Patricia Eileen Saxton
-
Publication number: 20190010400Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: September 13, 2018Publication date: January 10, 2019Applicant: MERCK PATENT GMBHInventors: Kevin ADLEM, Owain Llyr PARRI, Rachel TUFFIN, Patricia Eileen SAXTON, Mariam NAMUTEBI, Benjamin SNOW
-
Patent number: 10048420Abstract: The invention relates to reactive mesogens (RMs) comprising a terphenyl group, to mixtures and formulations comprising them, to polymers obtained form such RMs and RM mixtures, and the use of the RMs, RM mixtures and polymers in optical or electrooptical components or devices, like optical retardation films for liquid crystal displays (LCDs).Type: GrantFiled: November 18, 2013Date of Patent: August 14, 2018Assignee: MERCK PATENT GMBHInventors: Kevin Adlem, Owain Llyr Parri, Graham Smith, Patricia Eileen Saxton, Mariam Namutebi, Vicki Cook, Joseph Sargent
-
Patent number: 9914876Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: GrantFiled: June 14, 2013Date of Patent: March 13, 2018Assignee: Merck Patent GmbHInventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton, Benjamin Snow, Mark John Goulding, Nathan Smith
-
Publication number: 20170342324Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12 and CG1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: November 23, 2015Publication date: November 30, 2017Applicant: Merck Patent GmbHInventors: Kevin ADLEM, Patricia Eileen SAXTON
-
Publication number: 20170327741Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: December 8, 2015Publication date: November 16, 2017Applicant: Merck Patent GmbHInventors: Detlef PAULUTH, Kevin ADLEM, Owain Llyr PARRI, Rachel TUFFIN, Hassan ARASI, Patricia Eileen SAXTON
-
Patent number: 9758727Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: GrantFiled: November 27, 2014Date of Patent: September 12, 2017Assignee: Merck Patent GmbHInventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton
-
Patent number: 9644144Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: GrantFiled: August 14, 2013Date of Patent: May 9, 2017Assignee: MERCK PATENT GMBHInventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton, Mariam Namutebi, Benjamin Snow
-
Publication number: 20170002268Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: November 27, 2014Publication date: January 5, 2017Applicant: Merck Patent GmbHInventors: Kevin ADLEM, Owain Llyr PARRI, Rachel TUFFIN, Patricia Eileen SAXTON
-
Publication number: 20160289561Abstract: The invention relates to compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of these compounds of formula I in liquid crystal media and to respective devices comprising a liquid crystal medium according to the present invention and in particular to flexoelectric liquid crystal devices.Type: ApplicationFiled: October 23, 2014Publication date: October 6, 2016Applicant: Merck Patent GmbHInventors: Kevin ADLEM, Owain Llyr PARRI, Rachel TUFFIN, Patricia Eileen SAXTON, Mariam NAMUTEBI, Benjamin SNOW, Rebecca PROCTOR, Simon SIEMIANOWSKI
-
Publication number: 20160222293Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, CG1, MG1, X11, X12 and Sp1 have the meaning given in claim 1, to the use of mesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: August 13, 2014Publication date: August 4, 2016Applicant: MERCK PATENT GMBHInventors: Kevin ADLEM, Owain Llyr PARRI, Rachel TUFFIN, Patricia Eileen SAXTON, Mariam NAMUTEBI, Benjamin SNOW
-
Publication number: 20150323722Abstract: The invention relates to reactive mesogens (RMs) comprising a terphenyl group, to mixtures and formulations comprising them, to polymers obtained form such RMs and RM mixtures, and the use of the RMs, RM mixtures and polymers in optical or electrooptical components or devices, like optical retardation films for liquid crystal displays (LCDs).Type: ApplicationFiled: November 18, 2013Publication date: November 12, 2015Applicant: MERCK PATENT GMBHInventors: Kevin ADLEM, Owain Llyr PARRI, Graham SMITH, Patricia Eileen SAXTON, Mariam NAMUTEBI, Vicki COOK, Joseph SARGENT
-
Publication number: 20150210921Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: August 14, 2013Publication date: July 30, 2015Applicant: Merck Patent GmbHInventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton, Mariam Namutebi, Benjamin Snow
-
Publication number: 20150203755Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: June 14, 2013Publication date: July 23, 2015Applicant: Merck Patent GmbHInventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton, Benjamin Snow, Mark John Goulding, Nathan Smith
-
Publication number: 20150203756Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: June 14, 2013Publication date: July 23, 2015Applicant: MERCK PATENT GMBHInventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton, Mariam Namutebi, Benjamin Snow
-
Publication number: 20150175883Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Type: ApplicationFiled: June 14, 2013Publication date: June 25, 2015Applicant: Merck Patent GmbHInventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton, Mariam Namutebi, Benjamin Snow
-
Publication number: 20140232977Abstract: The invention relates to bimesogenic compounds of formula I R1-MG1-Sp-MG2-R2??I wherein R1, R2, MG1, MG2 and Sp have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention. Furthermore the invention relates to bimesogenic compounds of formula I inducing a second nematic phase in nematic mixtures that do not show this additional phase without compounds of formula I.Type: ApplicationFiled: June 12, 2012Publication date: August 21, 2014Applicant: MERCK PATENT GMBHInventors: Kevin Adlem, David Wilkes, Patricia Eileen Saxton, Benjamin Snow, Rachel Tuffin, Owain Llyr Parri, Geoffrey Luckhurst
-
Patent number: 8687259Abstract: The invention relates to a polymerizable LC material with negative optical dispersion, a polymer film with negative optical dispersion obtainable from such a material, and the use of the polymerizable LC material and polymer film in optical, electrooptical, electronic, semiconducting or luminescent components or devices.Type: GrantFiled: October 6, 2010Date of Patent: April 1, 2014Assignee: Merck Patent GmbHInventors: Kevin Adlem, Owain Llyr Parri, David Wilkes, Patricia Eileen Saxton
-
Publication number: 20120224245Abstract: The invention relates to a polymerisable LC material with negative optical dispersion, a polymer film with negative optical dispersion obtainable from such a material, and the use of the polymerisable LC material and polymer film in optical, electrooptical, electronic, semiconducting or luminescent components or devices.Type: ApplicationFiled: October 6, 2010Publication date: September 6, 2012Applicant: MERCK PATENT GESELLSCHAFT MIT BESCRANKTER HAFTUNGInventors: Kevin Adlem, Owain Parri, David Wilkes, Patricia Eileen Saxton
-
Patent number: 7943061Abstract: The invention relates to chiral compounds, methods of their preparation, and to their use in optical, electrooptical, electronic, semiconducting or luminescent components or devices, and in decorative, security, cosmetic or diagnostic applications.Type: GrantFiled: March 16, 2007Date of Patent: May 17, 2011Assignee: Merck Patent Gesellschaft mit beschrankter HaftungInventors: Louise Diane Farrand, Patricia Eileen Saxton